MCI Multispecialty Grand Rounds – PARP Inhibition for Ovarian Cancer

Miami, FL US
October 8, 2018

Slow progress in improving the outcome of ovarian cancer with chemotherapy over the last decade has stimulated research into molecularly targeted therapy. Poly (ADP-ribose) polymerase (PARP) inhibitors target DNA repair and are specifically active in cells that have impaired repair of DNA by the homologous recombination (HR) pathway.  
Dr. Konner will discuss how the current practice is evolving and assist physicians in understanding the mechanism of PARP inhibition.

Target Audience

Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, General Surgeons, General Practitioners, Obstetrics and Gynecologists, Oncologists, Radiation Oncologists, Nurses, Patient Navigators and all other interested healthcare professionals.

Learning Objectives

  • Summarize and explain the mechanism of PARP inhibition.
  • Identify appropriate indications for PARP treatment use.
  • Assess and manage associated toxicities.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Nursing
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Occupational Therapy
  • 1.00 Florida Board of Pharmacy
  • 1.00 Florida Board of Respiratory Therapy
  • 1.00 General certificate of attendance
Course opens: 
08/02/2018
Course expires: 
11/23/2018
Event starts: 
10/08/2018 - 7:30am
Event ends: 
10/08/2018 - 8:30am
Rating: 
0
Miami Cancer Institute
8900 N. Kendall Dr
MCI – Tumor Board Room
Miami, FL 33176
United States

Jason Konner, M.D.
Section Head for Ovarian Cancer
Associate Member
Gynecologic Medical Oncology Service
New York, New York and
Monmouth County, N.J.
Memorial Sloan Kettering
Cancer Institute

Jason Konner, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1 credit hour, CE Broker Course #20-680158, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 1 credit hour for Nurses and Nurse Practitioners. Baptist Health South Florida CE Broker Provider #50-182.
 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Nursing
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Occupational Therapy
  • 1.00 Florida Board of Pharmacy
  • 1.00 Florida Board of Respiratory Therapy
  • 1.00 General certificate of attendance

Accreditation Period

Course opens: 
08/02/2018
Course expires: 
11/23/2018
Please login or register to take this course.

NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support